Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s): IPCIF

Healthcare

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its product portfolio includes Oxycodone Hydrochloride ER, Regabatin, Dexmethylphenidate ER, Metformin ER, Venlafaxine ER, Pantoprazole ER, Quetiapine ER, Lamotrigine ER, Levetiracetam ER, Desvenlafaxine ER, Ranolazine ER, and Carvedilol ER. Its product portfolio includes both new products and controlled-release generic products. It also provides analytical services.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc > here we go news on the way bottom up insome hold long too

<< Previous

Bullboard Posts

Next >>

Comment by biggerron Oct 21, 2019 12:49pm

85 Views

Post# 30251585

RE:here we go news on the way bottom up insome hold long too

I think they'll have to find some replacement for Mallinckrodt to sell their drugs Also I like how every time they make a PR they say that there is no guarantee that they'll sell any of their drugs or that they get an FDA approval or even if they'll exist tomorrow or an asteroid won't hit the Earth and so on, ha

<< Previous

Bullboard Posts

Next >>

Why Roth Capital Partners gives GameSquare a 'buy' rating